Coming soon: The Life Sciences Industry Report 2025 – insigh...
Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
Neuralink gets okay for its first international trial
Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada
Is Martin Makary Trump's pick for FDA Commissioner?
US President-elect Donald Trump is reported to be considering the nomination of Johns Hopkins surgeon and writer Martin Makary to lead the FDA
FDA experts lukewarm on AZ's anticoagulant antidote Andexxa
AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US
Jazz gets first FDA nod for HER2 bispecific Ziihera
Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
9th Commercialising Continuous Processing Summit 2025
The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
9th Liquid Biopsy for Precision Oncology Summit
9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
Returning... The 5th Operationalize Expanded Access Programs...
Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
LEAP HR: Life Sciences Europe
Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
Patient Recruitment for Rare Disease Trials Summit
Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.